SCV
BIOA

Sands Capital Ventures’s BioAge Labs BIOA Stock Holding History

Sands Capital Ventures’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Hold
786,353
– – 3.14% 10
2026
Q1 		$13.8M Hold
786,353
– – 3.27% 9
2025
Q4 		$10.4M Hold
786,353
– – 2.01% 10
2025
Q3 		$4.62M Hold
786,353
– – 1.01% 16
2025
Q2 		$3.25M Hold
786,353
– – 0.64% 16
2025
Q1 		$2.96M Hold
786,353
– – 0.72% 18
2024
Q4 		$4.55M Sell
786,353
-300,000
-28% -$5.17M 0.99% 17
2024
Q3 		$22.6M Buy
+1,086,353
New +$21.8M 6.35% 4

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Sands Capital Ventures's BIOA Position: Q2 2026 in Review

Sands Capital Ventures held its BioAge Labs (BIOA) position steady in Q2 2026 at 786,353 shares worth $19.3M. The position accounts for 3.14% of the portfolio, ranked #10.

Sands Capital Ventures first reported a position in BIOA in Q3 2024 and has held it in 8 quarters since. The position peaked at $22.6M in Q3 2024. 139 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Sands Capital Ventures held 786,353 shares of BioAge Labs worth $19.3M as of Q2 2026.
  • Sands Capital Ventures left its BioAge Labs share count unchanged in Q2 2026.
  • BioAge Labs made up 3.14% of Sands Capital Ventures's portfolio in Q2 2026, its #10 holding.
  • Sands Capital Ventures first reported a position in BioAge Labs in Q3 2024 and has held it in 8 quarters since.
  • Sands Capital Ventures's BioAge Labs position peaked at $22.6M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Sands Capital Ventures's 13F filing for Q2 2026, filed 13 Aug 2026.